Brain Fog Supplement Study: 8-Week Cognitive Scores for 39 Participants
by Abeer M. Al-Ghananeem·Updated 1mo ago
791.3 KB3files
Available on 1 platform
Sign in to view source links and access this dataset
Description
39 adults with self-reported brain fog symptoms participated in an 8-week open-label study evaluating a dietary supplement. The study, authored by Abeer M. Al-Ghananeem and published on figshare in 2026, measured changes in Montreal Cognitive Assessment scores and self-reported survey results. Results showed significant improvements across all domains by Week 8, with repeated-measures ANOVA indicating a significant time effect (F [2.811, 105.4] = 43.09, p < 0.0001).
Use Cases
Analyze the correlation between supplement use and cognitive score changes based on the Montreal Cognitive Assessment data mentioned.
Model time-series trends in self-reported cognitive symptoms over an 8-week period based on the repeated-measures design.
Benchmark baseline and follow-up cognitive scores for a cohort with brain fog symptoms described in the study.
Investigate the feasibility and tolerability of a multi-component intervention based on participant completion rates and survey data.
Strengths
Includes specific statistical results (F [2.811, 105.4] = 43.09, p < 0.0001) from repeated-measures analysis of variance.
Study design details are provided, including an 8-week duration and a cohort of 39 participants.
Primary and secondary outcomes are clearly defined as changes in Montreal Cognitive Assessment and self-reported survey scores.
Limitations
Row count is unknown, which may limit suitability assessment.
Column-level documentation is absent; field semantics must be inferred after download.
The open-label, single-arm design without a placebo group, as noted in the description, limits causal inference.